State Street Corp I Bio, Inc. Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $854,072 - $1.71 Million	-3,713,359 Reduced 82.8%	771,521 $204,000
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $20,681 - $42,052	-68,939 Reduced 1.51%	4,484,880 $1.92 Million
Q4 2021 Feb 14, 2022	SELL	$0.55 - $1.04 $17,594 - $33,269	-31,990 Reduced 0.7%	4,553,819 $2.5 Million
Q3 2021 Nov 15, 2021	BUY	$1.06 - $1.52 $783,784 - $1.12 Million	739,419 Added 19.22%	4,585,809 $4.86 Million
Q2 2021 Aug 16, 2021	BUY	$1.22 - $1.65 $1.12 Million - $1.51 Million	914,209 Added 31.18%	3,846,390 $5.81 Million
Q1 2021 May 17, 2021	BUY	$1.18 - $2.62 $969,495 - $2.15 Million	821,606 Added 38.93%	2,932,181 $4.52 Million
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.24 $1.32 Million - $2.83 Million	1,261,293 Added 148.51%	2,110,575 $2.22 Million
Q3 2020 Nov 10, 2020	BUY	$1.7 - $6.41 $603,668 - $2.28 Million	355,099 Added 71.86%	849,282 $1.72 Million
Q2 2020 Aug 14, 2020	BUY	$0.87 - $2.46 $429,939 - $1.22 Million	494,183 New	494,183 $1.1 Million

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.